CN111671817A - A Chinese medicinal composition for treating thick blood lipid and its preparation method - Google Patents
A Chinese medicinal composition for treating thick blood lipid and its preparation method Download PDFInfo
- Publication number
- CN111671817A CN111671817A CN202010649192.4A CN202010649192A CN111671817A CN 111671817 A CN111671817 A CN 111671817A CN 202010649192 A CN202010649192 A CN 202010649192A CN 111671817 A CN111671817 A CN 111671817A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw materials
- traditional chinese
- chinese medicine
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 36
- 239000008280 blood Substances 0.000 title claims abstract description 36
- 150000002632 lipids Chemical class 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims description 10
- 239000003814 drug Substances 0.000 claims abstract description 73
- 239000002994 raw material Substances 0.000 claims abstract description 49
- 238000001035 drying Methods 0.000 claims abstract description 26
- 238000002156 mixing Methods 0.000 claims abstract description 22
- 230000001603 reducing effect Effects 0.000 claims abstract description 22
- 238000002791 soaking Methods 0.000 claims abstract description 21
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 20
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 20
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 20
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 20
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 20
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 20
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 20
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 20
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 20
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 20
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 20
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 20
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 20
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 20
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 20
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 20
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 19
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 19
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 19
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 19
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 19
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 19
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 18
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 15
- 208000007536 Thrombosis Diseases 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 13
- 208000031226 Hyperlipidaemia Diseases 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 241000758794 Asarum Species 0.000 claims abstract description 10
- 230000002537 thrombolytic effect Effects 0.000 claims abstract description 9
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 7
- 238000000227 grinding Methods 0.000 claims abstract description 6
- 230000008569 process Effects 0.000 claims abstract description 6
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 5
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 5
- 239000007788 liquid Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000009835 boiling Methods 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 11
- 238000010411 cooking Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 235000013719 Houttuynia cordata Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 230000006870 function Effects 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 208000030159 metabolic disease Diseases 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 abstract description 2
- 229930186217 Glycolipid Natural products 0.000 abstract description 2
- 238000000338 in vitro Methods 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 206010002482 Angiosclerosis Diseases 0.000 abstract 1
- 238000010025 steaming Methods 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 15
- 241000218628 Ginkgo Species 0.000 description 15
- 241000229143 Hippophae Species 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a lipid-lowering thrombolytic traditional Chinese medicine composition for treating thick blood lipid, which comprises the following raw material medicines in parts by weight: the traditional Chinese medicine is prepared from the following raw material medicines: honeysuckle, hawthorn, dark plum, sea-buckthorn, ginkgo, peach kernel, cassia seed, kudzu root, heartleaf houttuynia herb, pseudo-ginseng, yeast and white granulated sugar; the main process flow is as follows: selecting, drying, grinding, mixing, soaking, steaming, filtering, blending and fermenting; the traditional Chinese medicine composition for treating thick blood fat, reducing fat and dissolving thrombus, provided by the application document, has no application report of the composition, has a remarkable blood fat reducing effect and small side effect, and has a remarkable treatment effect on symptoms and diseases such as hyperlipidemia, angiosclerosis and the like caused by glycolipid metabolic disorder; has the obvious functions of reducing blood fat and dissolving thrombus and also has the obvious functions of dissolving thrombus in vivo and in vitro.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a lipid-lowering thrombolytic traditional Chinese medicine composition for treating thick blood lipid and a preparation method thereof.
Background
Hyperlipidemia is a common and frequent metabolic disease, is common in middle-aged and elderly people, but with the continuous improvement of living standard of people, the change of dietary structure and the increase of drinking capacity, the morbidity of young people is also increased year by year, and hyperlipidemia is an important factor for inducing coronary atherosclerotic heart disease, cerebral arteriosclerosis, cerebral thrombosis and the like. The traditional Chinese medicine does not have the name of hyperlipemia, belongs to the categories of blood stasis, phlegm turbidity, damp turbidity, food retention and the like, and is the syndrome of deficiency in origin and marked excess in nature. The formation of hyperlipidemia is caused by stagnation of blood in the vein due to qi deficiency of spleen and kidney and inability to transport blood; in addition, improper diet, a person who is addicted to the fat, sweet and thick taste may injure the spleen and stomach, resulting in dysfunction of transportation and transformation, phlegm-dampness in the interior and indigestion. Therefore, the treatment aims at tonifying kidney and spleen, tonifying qi and promoting transportation, removing stasis and phlegm, and promoting diuresis and removing food retention. From the viewpoint of modern medicine, the lipid-lowering effect of traditional Chinese medicines is mainly reflected in inhibiting the absorption of cholesterol, regulating the metabolism of blood lipid and promoting the excretion of cholesterol.
In recent years, with the continuous and deep research and development of the traditional Chinese medicine for reducing blood fat, the traditional Chinese medicine is proved to have the effects of reducing blood fat in multiple ways and multiple targets and broad spectrum and preventing atherosclerosis, and has few adverse reactions. However, clinical research on the traditional Chinese medicine for reducing blood fat is not enough, and research mechanisms of effective components, action modes, ways and targets of the traditional Chinese medicine for exerting curative effect are unclear. Although some studies have conducted clinical trials, most of the studies mainly use decoction, which is inconvenient for long-term administration, and thus the popularization of the decoction is affected. Moreover, a part of the prescription forms more expensive medicines, and the economic burden is large after long-term taking. Therefore, modern research technology is needed to develop basic research of traditional Chinese medicine from the aspects of immunity and molecular biology, and clinical guidance basis is provided for the traditional Chinese medicine to treat hyperlipidemia. Meanwhile, the traditional Chinese medicine for treating hyperlipidemia should be based on the principle of simplicity, test and cheapness, so that the traditional Chinese medicine can be popularized and used.
At present, China has low consciousness on prevention and treatment of hyperlipidemia, and particularly the attention degree of rural residents on prevention and treatment of hypertension and hyperlipidemia should be strengthened. Therefore, in order to prevent and treat the increasingly-growing hyperlipemia and related cardiovascular and cerebrovascular patients in the world, the deep research on food and medicinal plants with the lipid-lowering function is carried out, and the great significance is brought to the effort of finding and developing the lipid-lowering medicament with remarkable lipid-lowering effect and without any toxic or side effect.
The invention content is as follows:
the invention aims to solve the problems in the prior art, and provides a lipid-lowering thrombolytic traditional Chinese medicine composition for treating thick blood lipid and a preparation method thereof.
In order to solve the above problems, the present invention provides a technical solution:
a traditional Chinese medicine composition for treating thick blood lipid, lowering lipid and dissolving thrombus is prepared from the following raw materials: honeysuckle, hawthorn, dark plum, sea-buckthorn, ginkgo, peach kernel, cassia seed, kudzu root, heartleaf houttuynia herb, pseudo-ginseng, yeast and white granulated sugar.
Preferably, 20 to 30 parts of honeysuckle, 7 to 14 parts of hawthorn, 2 to 5 parts of dark plum, 10 to 15 parts of sea-buckthorn, 5 to 9 parts of ginkgo, 12 to 18 parts of peach kernel, 5 to 10 parts of cassia seed, 36 to 45 parts of kudzuvine root, 10 to 20 parts of heartleaf houttuynia herb, 8 to 12 parts of pseudo-ginseng, yeast and white granulated sugar.
Preferably, the traditional Chinese medicine composition comprises 25 parts of honeysuckle, 11 parts of hawthorn, 3 parts of dark plum, 13 parts of sea buckthorn, 7 parts of ginkgo, 15 parts of peach kernel, 7 parts of cassia seed, 40 parts of kudzu root, 15 parts of houttuynia cordata, 10 parts of pseudo-ginseng, yeast and white granulated sugar.
A preparation method of a traditional Chinese medicine composition for treating thick blood lipid, reducing fat and dissolving thrombus comprises the following main process flows: selecting materials, drying, grinding, mixing materials, soaking, cooking, filtering residues, blending and fermenting, wherein the specific operation method comprises the following steps in sequence:
A. selecting 25g of honeysuckle, 11g of hawthorn, 3g of dark plum, 13g of sea buckthorn, 7g of ginkgo, 15g of peach kernel, 7g of cassia seed, 40g of kudzu root, 15g of cordate houttuynia and 10g of pseudo-ginseng, which meet the national sanitation and quality standard;
B. drying, respectively slicing the selected raw materials, drying in a drying oven at 80-100 deg.C for 60 min to evaporate water content of the raw materials, drying to below 10%, and sterilizing;
C. crushing the dried raw materials, and respectively crushing for later use;
D. proportioning and uniformly mixing various flaky raw materials in parts by weight;
E. soaking, namely soaking the mixed raw materials in warm water, adding water with the mass 5 times of that of the total raw materials, and soaking for 40 minutes;
F. and E, boiling, namely putting the traditional Chinese medicine raw materials soaked in the step E into a boiling pot, adding water with the mass 5 times of that of the total raw materials, and boiling for 30 minutes.
G. And F, filtering residues in the liquid medicine decocted in the step F, and meanwhile, putting the liquid medicine into a container until the temperature of the liquid medicine in the container is 50 ℃.
H. And D, blending the white granulated sugar left in the step A and the liquid medicine according to the weight ratio of 1 to 10.
I. And (D) fermenting, namely adding the liquid medicine blended in the step (H) into yeast with the mass being one percent of the liquid medicine. Fermenting at constant temperature of 30 deg.C for three months.
Preferably, the containers required in the steps G, H and I are food-grade containers.
The effects of the raw materials of the invention are as follows:
honeysuckle flower: flos Lonicerae has effects of clearing heat and detoxicating, dredging meridian passage, caring skin, lowering blood pressure, reducing serum cholesterol, increasing coronary blood flow, and preventing coronary atherosclerotic heart disease and angina pectoris; inhibiting the formation of cerebral thrombosis; improving microcirculation, removing fat deposition, promoting metabolism, delaying aging, caring skin, and removing speckle;
the hawthorn has the effects of reducing blood fat, blood pressure, strengthening heart, resisting arrhythmia and the like, is also a good medicine for strengthening spleen, stimulating appetite, promoting digestion, removing stagnation, promoting blood circulation and reducing phlegm, and has good curative effects on symptoms such as chest, diaphragm, spleen fullness, hernia, blood stasis, amenorrhea and the like;
wu Mei has the effects of astringing lung, astringing intestine, promoting fluid production and calming ascaris. It is commonly indicated for chronic cough due to lung deficiency, chronic diarrhea and dysentery, diabetes due to deficiency heat, vomiting and abdominal pain due to ascariasis;
the sea buckthorn contains a large amount of vitamin E, vitamin A, flavone and the like, has special pharmacological properties of resisting fatigue, enhancing organism vitality, resisting cancer and the like, has the medicinal properties of protecting and accelerating the repair of gastric mucosa, increasing intestinal bifidobacteria, has the effects of reducing plasma cholesterol and reducing the content of cholesterol in blood vessel walls, can prevent and treat hyperlipidemia and atherosclerosis, and has the effect of promoting wound healing;
ginkgo seed and Ginkgo seed are sweet, bitter, astringent and even in flavor, are toxic, and have the functions of astringing lung qi, relieving asthma and cough, stopping leukorrhagia and reducing urination. Can be used for treating asthma, cough, leucorrhea, whitish and turbid urine, nocturnal emission, gonorrhea, frequent micturition, etc.;
peach kernel has the functions of promoting blood circulation to disperse blood clots, relaxing bowels, relieving cough and asthma. Can be used for treating amenorrhea, dysmenorrhea, abdominal mass, pulmonary abscess, acute appendicitis, traumatic injury, intestinal dryness, constipation, cough, and asthma;
semen Cassiae and semen Cassiae have bitter, sweet and salty taste, and slightly cold property, and enter liver, kidney and large intestine meridians; loosening bowel to relieve constipation, reducing blood lipid, improving eyesight, and treating constipation, hyperlipemia, and hypertension. Clearing liver-fire, improving eyesight, promoting diuresis, relaxing bowels, lowering blood pressure, and reducing blood lipid;
kudzu root, sweet, pungent and cool. Has the functions of expelling pathogenic factors from muscles, allaying fever, promoting eruption, promoting the production of body fluid to quench thirst, invigorating yang and stopping diarrhea. It is commonly used for exterior syndrome with fever, strong pain of neck and back, measles without adequate eruption, thirst due to fever, diabetes due to yin deficiency, dysentery due to heat-purging and diarrhea due to spleen deficiency;
yu xing Cao is pungent in flavor and cold in nature, and enters lung meridian. It has effects of clearing away heat and toxic materials, relieving swelling, treating sore, inducing diuresis, removing dampness, clearing away heat, relieving dysentery, invigorating stomach, and resolving food stagnation, and can be used for treating lung abscess, pyocutaneous disease, hemorrhoid hematochezia, and heat accumulation of spleen and stomach due to excess heat, heat toxin, dampness, and disease heat. Modern pharmacological experiments show that the product has antibacterial, antiviral, immunity improving, and diuretic effects;
pseudo-ginseng (alias pseudo-ginseng): nature and taste: sweet, slightly bitter and warm. Enter liver, stomach and large intestine meridians. The functions are as follows: stop bleeding, dissipate blood stasis, resolve swelling and alleviate pain. Can be used for treating hematemesis, hemoptysis, and abdominal mass.
Has the advantages that: the invention has the beneficial effects that: the application document provides a lipid-lowering thrombolytic traditional Chinese medicine composition for treating thick blood lipid, and application reports of the composition are not seen before, so that the composition has a remarkable lipid-lowering effect and small side effects, and has a remarkable treatment effect on symptoms and diseases such as hyperlipidemia and vascular sclerosis caused by glycolipid metabolic disorder; has the obvious functions of reducing blood fat and dissolving thrombus and also has the obvious functions of dissolving thrombus in vivo and in vitro.
The specific implementation mode is as follows:
the present invention is further described with reference to the specific embodiments and the test examples, but the present invention is not limited to the embodiments, and those skilled in the art will understand that modifications and equivalent substitutions can be made on the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention, and the technical solution of the present invention shall be covered by the claims of the present invention.
In addition, the following examples and experimental methods, unless otherwise specified, are all conventional methods; the agents and medicaments, if not specified, are commercially available:
example (b):
a traditional Chinese medicine composition for treating thick blood lipid, lowering lipid and dissolving thrombus is prepared from the following raw materials: honeysuckle, hawthorn, dark plum, sea-buckthorn, ginkgo, peach kernel, cassia seed, kudzu root, heartleaf houttuynia herb, pseudo-ginseng, yeast and white granulated sugar.
Preferably, 20 parts of honeysuckle, 7 parts of hawthorn, 2 parts of dark plum, 10 parts of sea-buckthorn, 5 parts of ginkgo, 12 parts of peach kernel, 5 parts of cassia seed, 36 parts of kudzu root, 10 parts of heartleaf houttuynia herb, 8 to 12 parts of pseudo-ginseng, yeast and white granulated sugar.
A preparation method of a traditional Chinese medicine composition for treating thick blood lipid, reducing fat and dissolving thrombus comprises the following main process flows: selecting materials, drying, grinding, mixing materials, soaking, cooking, filtering residues, blending and fermenting, wherein the specific operation method comprises the following steps in sequence:
A. selecting 20g of honeysuckle, 7g of hawthorn, 2g of dark plum, 10g of sea-buckthorn, 5g of ginkgo, 12g of peach kernel, 5g of cassia seed, 36g of kudzu root, 10g of heartleaf houttuynia herb and 8-12 g of pseudo-ginseng according to the weight ratio of the raw materials;
B. drying, respectively slicing the selected raw materials, drying in a drying oven at 80-100 deg.C for 60 min to evaporate water content of the raw materials, drying to below 10%, and sterilizing;
C. crushing the dried raw materials, and respectively crushing for later use;
D. proportioning and uniformly mixing various flaky raw materials in parts by weight;
E. soaking, namely soaking the mixed raw materials in warm water, adding water with the mass 5 times of that of the total raw materials, and soaking for 40 minutes;
F. and E, boiling, namely putting the traditional Chinese medicine raw materials soaked in the step E into a boiling pot, adding water with the mass 5 times of that of the total raw materials, and boiling for 30 minutes.
G. And F, filtering residues in the liquid medicine decocted in the step F, and meanwhile, putting the liquid medicine into a container until the temperature of the liquid medicine in the container is 50 ℃.
H. And D, blending the white granulated sugar left in the step A and the liquid medicine according to the weight ratio of 1 to 10.
I. And (D) fermenting, namely adding the liquid medicine blended in the step (H) into yeast with the mass being one percent of the liquid medicine. Fermenting at constant temperature of 30 deg.C for three months.
Preferably, the containers required in the steps G, H and I are food-grade containers.
In the specific embodiment 2, the method comprises the following steps of,
the embodiment provides a lipid-lowering thrombolytic traditional Chinese medicine composition for treating thick blood lipid, which is prepared from the following raw material medicines: honeysuckle, hawthorn, dark plum, sea-buckthorn, ginkgo, peach kernel, cassia seed, kudzu root, heartleaf houttuynia herb, pseudo-ginseng, yeast and white granulated sugar.
Preferably, 30 parts of honeysuckle, 14 parts of hawthorn, 5 parts of dark plum, 15 parts of sea-buckthorn, 9 parts of ginkgo, 18 parts of peach kernel, 10 parts of cassia seed, 45 parts of kudzuvine root, 20 parts of heartleaf houttuynia herb, 2 parts of pseudo-ginseng, yeast and white granulated sugar.
A preparation method of a traditional Chinese medicine composition for treating thick blood lipid, reducing fat and dissolving thrombus comprises the following main process flows: selecting materials, drying, grinding, mixing materials, soaking, cooking, filtering residues, blending and fermenting, wherein the specific operation method comprises the following steps in sequence:
A. selecting 30g of honeysuckle, 14g of hawthorn, 5g of dark plum, 15g of sea buckthorn, 9g of ginkgo, 18g of peach kernel, 10g of cassia seed, 45g of kudzuvine root, 20g of cordate houttuynia, 2g of pseudo-ginseng, yeast and white granulated sugar, wherein the honeysuckle, the hawthorn, the dark plum, the cassia seed and the white granulated sugar meet the national sanitation and quality standards;
B. drying, respectively slicing the selected raw materials, drying in a drying oven at 80-100 deg.C for 60 min to evaporate water content of the raw materials, drying to below 10%, and sterilizing;
C. crushing the dried raw materials, and respectively crushing for later use;
D. proportioning and uniformly mixing various flaky raw materials in parts by weight;
E. soaking, namely soaking the mixed raw materials in warm water, adding water with the mass 5 times of that of the total raw materials, and soaking for 40 minutes;
F. and E, boiling, namely putting the traditional Chinese medicine raw materials soaked in the step E into a boiling pot, adding water with the mass 5 times of that of the total raw materials, and boiling for 30 minutes.
G. And F, filtering residues in the liquid medicine decocted in the step F, and meanwhile, putting the liquid medicine into a container until the temperature of the liquid medicine in the container is 50 ℃.
H. And D, blending the white granulated sugar left in the step A and the liquid medicine according to the weight ratio of 1 to 10.
I. And (D) fermenting, namely adding the liquid medicine blended in the step (H) into yeast with the mass being one percent of the liquid medicine. Fermenting at constant temperature of 30 deg.C for three months.
Preferably, the containers required in the steps G, H and I are food-grade containers.
In a specific embodiment of the method of example 3,
the embodiment provides a lipid-lowering thrombolytic traditional Chinese medicine composition for treating thick blood lipid, which is prepared from the following raw material medicines: honeysuckle, hawthorn, dark plum, sea-buckthorn, ginkgo, peach kernel, cassia seed, kudzu root, heartleaf houttuynia herb, pseudo-ginseng, yeast and white granulated sugar.
Preferably, the traditional Chinese medicine composition comprises 25 parts of honeysuckle, 11 parts of hawthorn, 3 parts of dark plum, 13 parts of sea buckthorn, 7 parts of ginkgo, 15 parts of peach kernel, 7 parts of cassia seed, 40 parts of kudzu root, 15 parts of houttuynia cordata, 10 parts of pseudo-ginseng, yeast and white granulated sugar.
A preparation method of a traditional Chinese medicine composition for treating thick blood lipid, reducing fat and dissolving thrombus comprises the following main process flows: selecting materials, drying, grinding, mixing materials, soaking, cooking, filtering residues, blending and fermenting, wherein the specific operation method comprises the following steps in sequence:
A. selecting 25g of honeysuckle, 11g of hawthorn, 3g of dark plum, 13g of sea buckthorn, 7g of ginkgo, 15g of peach kernel, 7g of cassia seed, 40g of kudzu root, 15g of cordate houttuynia and 10g of pseudo-ginseng, which meet the national sanitation and quality standard;
B. drying, respectively slicing the selected raw materials, drying in a drying oven at 80-100 deg.C for 60 min to evaporate water content of the raw materials, drying to below 10%, and sterilizing;
C. crushing the dried raw materials, and respectively crushing for later use;
D. proportioning and uniformly mixing various flaky raw materials in parts by weight;
E. soaking, namely soaking the mixed raw materials in warm water, adding water with the mass 5 times of that of the total raw materials, and soaking for 40 minutes;
F. and E, boiling, namely putting the traditional Chinese medicine raw materials soaked in the step E into a boiling pot, adding water with the mass 5 times of that of the total raw materials, and boiling for 30 minutes.
G. And F, filtering residues in the liquid medicine decocted in the step F, and meanwhile, putting the liquid medicine into a container until the temperature of the liquid medicine in the container is 50 ℃.
H. And D, blending the white granulated sugar left in the step A and the liquid medicine according to the weight ratio of 1 to 10.
I. And (D) fermenting, namely adding the liquid medicine blended in the step (H) into yeast with the mass being one percent of the liquid medicine. Fermenting at constant temperature of 30 deg.C for three months.
Preferably, the containers required in the steps G, H and I are food-grade containers.
As an expanded technical scheme of the technical scheme, the Chinese herbal medicines can be extracted by alcohol selectively to achieve the purpose.
Description of the attached tables:
the attached table 1 shows the inhibition rate of the Chinese herbal medicine extract on the lipase activity:
attached table 1
A more or less "+" indicates a stronger or weaker lipase inhibition, and a more "+" indicates a stronger inhibition of the lipase.
While there have been shown and described what are at present considered to be the fundamental principles of the invention and its essential features and advantages, it will be understood by those skilled in the art that the invention is not limited by the embodiments described above, which are merely illustrative of the principles of the invention, but that various changes and modifications may be made therein without departing from the spirit and scope of the invention as defined by the appended claims and their equivalents.
Claims (5)
1. A traditional Chinese medicine composition for treating thick blood lipid, lowering lipid and dissolving thrombus is characterized by comprising the following raw materials: honeysuckle, hawthorn, dark plum, sea-buckthorn, ginkgo, peach kernel, cassia seed, kudzu root, heartleaf houttuynia herb, pseudo-ginseng, yeast and white granulated sugar.
2. The traditional Chinese medicine composition for treating thick blood lipid and reducing blood lipid and thrombolysis as claimed in claim 1, is characterized in that 20-30 parts of honeysuckle, 7-14 parts of hawthorn, 2-5 parts of dark plum, 10-15 parts of sea buckthorn, 5-9 parts of ginkgo, 12-18 parts of peach kernel, 5-10 parts of cassia seed, 36-45 parts of kudzu root, 10-20 parts of cordate houttuynia, 8-12 parts of pseudo-ginseng, yeast and white granulated sugar.
3. The traditional Chinese medicine composition for treating thick blood lipid and reducing blood lipid and thrombolysis of claim 1, which is characterized by comprising 25 parts of honeysuckle, 11 parts of hawthorn, 3 parts of dark plum, 13 parts of sea buckthorn, 7 parts of ginkgo, 15 parts of peach kernel, 7 parts of cassia seed, 40 parts of kudzuvine root, 15 parts of houttuynia cordata, 10 parts of pseudo-ginseng, yeast and white granulated sugar.
4. A preparation method of a traditional Chinese medicine composition for treating thick blood fat, reducing fat and dissolving thrombus is characterized by comprising the following main process flows: selecting materials, drying, grinding, mixing materials, soaking, cooking, filtering residues, blending and fermenting, wherein the specific operation method comprises the following steps in sequence:
A. selecting 25g of honeysuckle, 11g of hawthorn, 3g of dark plum, 13g of sea buckthorn, 7g of ginkgo, 15g of peach kernel, 7g of cassia seed, 40g of kudzu root, 15g of cordate houttuynia and 10g of pseudo-ginseng, which meet the national sanitation and quality standard;
B. drying, respectively slicing the selected raw materials, drying in a drying oven at 80-100 deg.C for 60 min to evaporate water content of the raw materials, drying to below 10%, and sterilizing;
C. crushing the dried raw materials, and respectively crushing for later use;
D. proportioning and uniformly mixing various flaky raw materials in parts by weight;
E. soaking, namely soaking the mixed raw materials in warm water, adding water with the mass 5 times of that of the total raw materials, and soaking for 40 minutes;
F. and E, boiling, namely putting the traditional Chinese medicine raw materials soaked in the step E into a boiling pot, adding water with the mass 5 times of that of the total raw materials, and boiling for 30 minutes.
G. And F, filtering residues in the liquid medicine decocted in the step F, and meanwhile, putting the liquid medicine into a container until the temperature of the liquid medicine in the container is 50 ℃.
H. And D, blending the white granulated sugar left in the step A and the liquid medicine according to the weight ratio of 1 to 10.
I. And (D) fermenting, namely adding the liquid medicine blended in the step (H) into yeast with the mass being one percent of the liquid medicine. Fermenting at constant temperature of 30 deg.C for three months.
5. The preparation method of the lipid-lowering thrombolytic Chinese medicinal composition for treating hyperlipidemia according to claim 3, wherein the containers required in the steps G, H and I are food-grade containers.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010649192.4A CN111671817A (en) | 2020-07-04 | 2020-07-04 | A Chinese medicinal composition for treating thick blood lipid and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010649192.4A CN111671817A (en) | 2020-07-04 | 2020-07-04 | A Chinese medicinal composition for treating thick blood lipid and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111671817A true CN111671817A (en) | 2020-09-18 |
Family
ID=72457345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010649192.4A Pending CN111671817A (en) | 2020-07-04 | 2020-07-04 | A Chinese medicinal composition for treating thick blood lipid and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111671817A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101797041A (en) * | 2009-02-11 | 2010-08-11 | 张仟 | Food eriosema chinense vinegar fluid with health care special efficacy |
| CN104435706A (en) * | 2014-11-17 | 2015-03-25 | 哈尔滨灵草舒生物科技有限公司 | Thrombolytic capsules capable of reducing fat and reducing sugar and production method thereof |
| CN105920514A (en) * | 2016-04-27 | 2016-09-07 | 青岛友诚高新技术有限公司 | Traditional Chinese medicinal composition for treating metabolic syndrome |
-
2020
- 2020-07-04 CN CN202010649192.4A patent/CN111671817A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101797041A (en) * | 2009-02-11 | 2010-08-11 | 张仟 | Food eriosema chinense vinegar fluid with health care special efficacy |
| CN104435706A (en) * | 2014-11-17 | 2015-03-25 | 哈尔滨灵草舒生物科技有限公司 | Thrombolytic capsules capable of reducing fat and reducing sugar and production method thereof |
| CN105920514A (en) * | 2016-04-27 | 2016-09-07 | 青岛友诚高新技术有限公司 | Traditional Chinese medicinal composition for treating metabolic syndrome |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105995720A (en) | Enzyme Laiyang pear paste and preparation method and application thereof | |
| CN110755542A (en) | Formula of uric acid-reducing gout-treating tea and preparation method thereof | |
| CN113975353A (en) | Medicine-food homologous nutrient solution formula for reducing uric acid and treating gout and preparation process thereof | |
| CN109820943B (en) | Zhuang medicine preparation for treating gout and preparation method thereof | |
| CN109481578A (en) | A kind of compound surrogated tea and preparation method thereof | |
| CN102599595B (en) | Health beverage with blood fat reducing function, traditional Chinese medicine and preparation method | |
| CN105494781A (en) | Giant knotweed rhizome health care tea for reducing blood glucose and lowering blood lipid | |
| CN111671817A (en) | A Chinese medicinal composition for treating thick blood lipid and its preparation method | |
| CN105012869A (en) | Liquor capable of stopping arthritis | |
| CN111772075A (en) | Solid beverage for clearing cardiovascular and cerebrovascular vessels | |
| CN111671027A (en) | Herbal solid beverage and preparation method thereof | |
| CN110201121A (en) | A kind of health-preserving medicinal liquor | |
| CN110973303A (en) | Instant weight-reducing tea | |
| CN104800600A (en) | Medicine for treating hypertension | |
| NL2037306B1 (en) | A nutritional product for clearing and protecting the lungs and a preparation method thereof | |
| CN115006491B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN114010755A (en) | Preparation for controlling uric acid and preparation method thereof | |
| CN112618637A (en) | Traditional Chinese medicine composition for reducing blood fat and preparation method thereof | |
| CN114947032A (en) | A solid beverage for improving blood quality and promoting nutrition balance | |
| CN115553418A (en) | Complementary food for conditioning diarrhea and preparation method thereof | |
| CN115989854A (en) | Medicinal and edible beverage | |
| CN117244028A (en) | Composition for alcoholic liver disease and preparation method and application thereof | |
| CN113893307A (en) | Composition for treating chronic gastritis and preparation method thereof | |
| CN118845867A (en) | A Chinese medicinal composition for clearing away heat and toxic materials and treating gastropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200918 |